Paper1703045
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.
Liotta LA and 2 others. Cell, 1991. Cited by 2,692 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Papers, record 1703045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1703045
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasm Metastasis | Major topic |
| Neoplasms | Major topic |
| Neovascularization, Pathologic | Major topic |
| Animals | |
| Endopeptidases | |
| Humans |
Source PubMed
Cited by678
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,692 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42737921 | Single-Molecule AFM-Based Force Spectroscopy Reveals VLA-4/VCAM-1 Interactions Underlying Chemokine-Independent B16 Melanoma Cell Arrest. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42737921 | PubMed |
| 42074287 | Chemokine-Independent VLA-4/VCAM-1-Mediated Rolling and Arrest of B16 Melanoma Cells Under Shear. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074287 | PubMed |
| 40926266 | Development and validation of a gastric cancer prognostic model utilizing lymphatic endothelial cell-related genes. | Diagn Pathol | 2025 | https://conductscience.org/library/papers/40926266 | PubMed |
| 40699873 | Integrating Genomics and Molecular Biology in Understanding Peritoneal Adhesion. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699873 | PubMed |
| 40265458 | Matrix Metalloproteinases in Glioma: Drivers of Invasion and Therapeutic Targets. | BioTech (Basel) | 2025 | https://conductscience.org/library/papers/40265458 | PubMed |
| 39744684 | Detecting metastatic potential of cancer through longitudinal vasculature imaging of biomaterial scaffold using non-invasive in vivo photoacoustic microscopy and optical coherence tomography. | Theranostics | 2025 | https://conductscience.org/library/papers/39744684 | PubMed |
| 39272978 | Correlation between Periostin Expression and Pro-Angiogenic Factors in Non-Small-Cell Lung Carcinoma. | Cells | 2024 | https://conductscience.org/library/papers/39272978 | PubMed |
| 39005669 | Prognostic significance of alpha-2-macrglobulin and low-density lipoprotein receptor-related protein-1 in various cancers. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39005669 | PubMed |
| 38900084 | SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2-Mediated Chromatin Remodeling. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38900084 | PubMed |
| 38859778 | Insight in Quinazoline-based HDAC Inhibitors as Anti-cancer Agents. | Mini Rev Med Chem | 2024 | https://conductscience.org/library/papers/38859778 | PubMed |
| 38693857 | Exploring the influence of microgravity on chemotherapeutic drug response in cancer: Unveiling new perspectives. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38693857 | PubMed |
| 38498903 | BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38498903 | PubMed |
| 38165551 | Reducing pediatric total-body PET/CT imaging scan time with multimodal artificial intelligence technology. | EJNMMI Phys | 2024 | https://conductscience.org/library/papers/38165551 | PubMed |
| 37936692 | Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer. | Front Immunol | 2023 | https://conductscience.org/library/papers/37936692 | PubMed |
| 37888452 | A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis. | Mar Drugs | 2023 | https://conductscience.org/library/papers/37888452 | PubMed |
| 37746644 | Osteopontin promotes gastric cancer progression via phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. | World J Gastrointest Oncol | 2023 | https://conductscience.org/library/papers/37746644 | PubMed |
| 37085921 | HOOK1 Inhibits the Progression of Renal Cell Carcinoma via TGF-β and TNFSF13B/VEGF-A Axis. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37085921 | PubMed |
| 36428760 | Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36428760 | PubMed |
| 35359855 | Design and Characterization of Paclitaxel-Loaded Polymeric Nanoparticles Decorated With Trastuzumab for the Effective Treatment of Breast Cancer. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35359855 | PubMed |
| 35110548 | Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells. | Nat Commun | 2022 | https://conductscience.org/library/papers/35110548 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1703045
GET https://conductscience.org/api/papers/v1/1703045/cited_by?page=2